Clinical Trial Update: Study of INV-102 Ophthalmic Solution in Adults With Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating INV-102 Ophthalmic Solution in adults with diabetic macular edema associated with non-proliferative diabetic retinopathy has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Diabetic Retinopathy
• Non-proliferative Diabetic Retinopathy

Drugs mentioned

• INV-102 Ophthalmic Solution (INV-102)

Snippet

Sponsor: Invirsa, Inc. | Conditions: Non-center Involved Diabetic Macular Edema, Non-center Involved Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy | Phase 2 | Status: COMPLETED